2Devroey D,Vantomme K,Betz W,et al.A Review of the treatment guidelines on the management of low levels of highdensity lipoprotein cholesterol [ J].Cardiology,2004,102(2):61-66.
3Couillard C,Despres JP,Lamarche B,et al.Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides:evidence from men of the health,risk factors,exercise training and genetics (HERITAGE) family study [ J ].Arterioscler Thromb Vasc Biol,2001,21(7):1226-1232.
4Expert Panel on Detection,Evaluation,and treatment of high blood cholesterol in adults.Executive summary of the third report of NCEP,expert panel on detection,evaluation and treatmeat of high blood cholesterol in adults [ J ].JAMA,2001,285(19):2486-2497.
5Friedewald WF,Levy RI,Fredrickson DS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma,without use of the preparative ultracentrifuge [ J ].Clin Chem,1972,18(6):499-502.
6Wang TD,Chen WJ,Chien KL,et al.Efficacy of cholesterol levels and retios in predicting future coronary heart disease in aChinese population[J].Am J Cardiol,2001,88(7):737-743.
7Takashi M,Osamu M,Osamu H,et al.LC AT-dependent conversion of pre[ beta] 1-HDL into [ alpha]-migrating HDL is severely delayed in hemodialysis patients [ J ].J Am Soc Nephrol,2003,14(3):732-738.
8Lee M,Kim J.Studies on the plasma lipid profiles,and LCAT and CETP activities according to hyperlipoproteinemia phenotypes(HLP) [J].Atherosclerosis,2001,159(1):381-389.
9Atger V,Giral P,Simon A,et al.High density lipoproteins subfractions as markers of early atherosclerosis[ J].Am J Cardiol,1995,75(1):127-131.
10Bizel R, Benhamou PY, Lardy B, et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patiens with type 2 diabetes and normal HDL cholesterol levels[J]. Diabetes Care, 2000, 23:1679-685.
4Kamstrup PR, Benn M, Tybjaerg-Hansen A, et al. Ex tremelipoprotein(a) leveIs and risks of myocardial infarction in th general population: the copenhagen city Heart study [ J ]. Circulation, 2008,117(2) : 176-184.
5Fruchart JC. Sacks FM. Herman8 MP, et al.. The residual risk reduction initiative:a carl to action to reduce residual vaneular risk in dyslipidemie patients. A condensed position paper by theresidual risk reduction initiative (R3i). Diabetes Vase Dis Res, 2008,5 : 319-335.
